Reference
|
Age/Sex
|
Race
|
HBV
|
HCV
|
EBV
|
Liver cirrhosis
|
Tumor no.
|
Tumor size(mm)
|
Treatment
|
FU, months
|
Outcomes
|
---|
Gearty et al [26]
|
28/F
|
Asian
|
+
|
–
|
+
|
NA
|
1
|
40
|
CT
|
9
|
Died
|
Ding et al [27]
|
75/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
15
|
LR
|
3
|
Alive
|
Ling et al [28]
|
64/M
|
Asian
|
+
|
–
|
+
|
–
|
1
|
20
|
LR
|
11
|
Alive
|
|
40/M
|
Asian
|
+
|
–
|
+
|
–
|
1
|
35
|
LR
|
32
|
Alive
|
Zhang et al [29]
|
38/F
|
Asian
|
+
|
–
|
+
|
–
|
1
|
28
|
LR
|
6
|
Alive
|
Shih et al [30]
|
77/F
|
White
|
+
|
–
|
–
|
+
|
2
|
17
|
LR
|
28
|
Alive
|
Tan et al [31]
|
22/M
|
White
|
NA
|
NA
|
+
|
NA
|
Multi
|
NA
|
CT
|
NA
|
Died
|
Adachi et al [32]
|
64/M
|
Asian
|
–
|
–
|
–
|
–
|
1
|
52
|
LR
|
3
|
Alive
|
Chen et al [33]
|
67/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
50
|
LR
|
<1
|
Died
|
|
41/M
|
Asian
|
+
|
–
|
–
|
+
|
1
|
30
|
LR
|
8
|
Alive
|
Henderson-Jackson et al [34]
|
63/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
40
|
LR
|
6
|
Alive
|
Hsu et al [35]
|
47/F
|
Asian
|
–
|
–
|
+
|
–
|
2
|
120
|
LR
|
48
|
Died
|
Huang et al [36]
|
60/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
35
|
NA
|
24
|
Alive
|
Hur et al [37]
|
57/F
|
Asian
|
–
|
–
|
–
|
–
|
1
|
20
|
LR
|
60
|
Alive
|
Jeng et al [38]
|
42/M
|
Asian
|
–
|
–
|
+
|
–
|
1
|
30
|
LR
|
84
|
Alive
|
|
67/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
30
|
LR
|
7
|
Alive
|
|
50/M
|
Asian
|
–
|
–
|
+
|
–
|
1
|
40
|
LR
|
16
|
Alive
|
|
50/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
40
|
LR
|
2
|
Alive
|
Kim et al [39]
|
64/M
|
Asian
|
–
|
+
|
–
|
+
|
1
|
20
|
LR
|
NA
|
NA
|
Labgaa et al [40]
|
58/M
|
Asian
|
+
|
–
|
+
|
–
|
1
|
22
|
LR
|
61
|
Alive
|
Lee [41]
|
79/M
|
Asian
|
+
|
–
|
–
|
+
|
2
|
35
|
LR
|
54
|
Alive
|
Liao et al [42]
|
35/F
|
NA
|
+
|
–
|
+
|
+
|
1
|
16
|
LR
|
NA
|
NA
|
Ortiz et al [43]
|
19/F
|
White
|
–
|
–
|
+
|
–
|
1
|
55
|
LR
|
44
|
Died
|
Szekely [44]
|
61/M
|
NA
|
–
|
–
|
–
|
–
|
1
|
60
|
NA
|
11
|
Alive
|
Vortmeyer et al [45]
|
71/F
|
White
|
–
|
–
|
+
|
–
|
2
|
50
|
NA
|
36
|
Alive
|
Chan et al [46]
|
53/F
|
Asian
|
+
|
–
|
+
|
+
|
1
|
16
|
LR
|
165
|
Alive
|
|
40/F
|
Asian
|
+
|
–
|
+
|
–
|
1
|
75
|
LR
|
56
|
Alive
|
|
57/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
71
|
LR
|
128
|
Alive
|
|
56F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
60
|
LR
|
69
|
Died
|
|
59/F
|
Asian
|
+
|
–
|
+
|
–
|
1
|
60
|
LR
|
72
|
Alive
|
|
45/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
30
|
LR
|
71
|
Alive
|
|
57/F
|
Asian
|
–
|
–
|
+
|
–
|
1
|
30
|
LR
|
58
|
Alive
|
Aosasa et al [47]
|
65/F
|
NA
|
–
|
+
|
–
|
–
|
1
|
64
|
LR
|
20
|
Alive
|
Min et al [48]
|
46/M
|
Asian
|
+
|
–
|
+
|
–
|
1
|
27
|
LR
|
84
|
Alive
|
- F female, M male, + positive, − negative, NA not available, HBV hepatitis B virus, HCV hepatitis C virus, EBV Epstein-Barr virus, no. number, LR liver resection, CT chemotherapy, OLT orthotopic liver transplant, FU follow-up, mo. months